date,title,source
Nov-06-18,Oncobiologics Advances ONS-5010 into wet AMD Clinical Trial,GlobeNewswire
Dec-03-18,Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy,GlobeNewswire
